Transient treatment of diabetic mice with two cytokines induces acinar-to-beta-cell conversion to an extent sufficient to durably restore normoglycemia.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Baeyens, L. et al. Nat. Biotechnol. 32, 76–83 (2014).
Pan, F.C. et al. Development 140, 751–764 (2013).
Thorel, F. et al. Nature 464, 1149–1154 (2010).
Bramswig, N.C. et al. J. Clin. Invest. 123, 1275–1284 (2013).
Zhou, Q., Brown, J., Kanarek, A., Rajagopal, J. & Melton, D.A. Nature 455, 627–632 (2008).
Lee, J. et al. Cell 151, 547–558 (2012).
Dor, Y., Brown, J., Martinez, O.I. & Melton, D.A. Nature 429, 41–46 (2004).
Gu, G., Dubauskaite, J. & Melton, D.A. Development 129, 2447–2457 (2002).
Miyatsuka, T. et al. Genes Dev. 20, 1435–1440 (2006).
Corcoran, R.B. et al. Cancer Res. 71, 5020–5029 (2011).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Worchel, H., Magnuson, M. Cytokine-driven beta-cell production in vivo. Nat Biotechnol 32, 63–64 (2014). https://doi.org/10.1038/nbt.2788
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt.2788